Volume | 108 630 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,166 | Bas Haut |
|||||
Minimum Bas | 0,1539 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,165 | 0,1539 | 0,166 | 0,159 | 0,1604 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
381 | 108 630 | US$ 0,1626936 | US$ 17 673 | - | 0,1159 - 1,52 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
00:07:01 | 51 | US$ 0,1566 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
2,5M | 15,61M | - | 13,27M | -5,15M | -0,33 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Sonoma Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
08/3/2024 | 22:29 | Edgar (US Regulatory) | Form 8-K - Current report |
08/3/2024 | 22:27 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
08/2/2024 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/1/2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
09/1/2024 | 22:47 | Edgar (US Regulatory) | Form 8-K - Current report |
29/12/2023 | 23:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report |
15/12/2023 | 23:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
21/11/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
Forum Action Sonoma Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Sonoma Pharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,148 | 0,1699 | 0,148 | 0,1568469 | 127 525 | 0,0035 | 2,36% |
1 mois | 0,153 | 0,185 | 0,138 | 0,1605282 | 372 924 | -0,0015 | -0,98% |
3 mois | 0,17 | 0,1919 | 0,1311 | 0,1579075 | 532 842 | -0,0185 | -10,88% |
6 mois | 0,185 | 0,3108 | 0,1159 | 0,1869203 | 1 537 684 | -0,0335 | -18,11% |
1 an | 0,991 | 1,52 | 0,1159 | 0,3625745 | 906 942 | -0,8395 | -84,71% |
3 ans | 8,00 | 13,36 | 0,1159 | 3,32 | 926 290 | -7,85 | -98,11% |
5 ans | 0,84 | 19,54 | 0,1159 | 4,37 | 681 069 | -0,6885 | -81,96% |